DekaBank Deutsche Girozentrale - MOMENTA PHARMACEUTICALS INC ownership

MOMENTA PHARMACEUTICALS INC's ticker is MNTA and the CUSIP is 60877T100. A total of 162 filers reported holding MOMENTA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
DekaBank Deutsche Girozentrale ownership history of MOMENTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$439,000
-44.5%
32,000
-50.0%
0.00%
-25.0%
Q2 2019$791,000
-32.5%
64,000
+43.8%
0.00%
-42.9%
Q1 2019$1,171,000
+185.6%
44,510
+14.9%
0.01%
+133.3%
Q4 2018$410,000
-65.0%
38,722
-13.0%
0.00%
-57.1%
Q3 2018$1,171,000
+40.9%
44,510
+6.6%
0.01%
+40.0%
Q2 2018$831,000
+22.9%
41,760
+9.9%
0.01%0.0%
Q1 2018$676,000
+8.9%
38,000
-2.1%
0.01%0.0%
Q4 2017$621,0000.0%38,8000.0%0.01%0.0%
Q3 2017$621,000
-6.3%
38,8000.0%0.01%0.0%
Q2 2017$663,000
+29.5%
38,8000.0%0.01%0.0%
Q1 2017$512,000
-18.6%
38,800
-7.8%
0.01%
-28.6%
Q4 2016$629,000
+42.0%
42,100
+8.2%
0.01%
+40.0%
Q3 2016$443,000
+7.5%
38,9000.0%0.01%0.0%
Q2 2016$412,000
+54.9%
38,900
+30.5%
0.01%
+66.7%
Q1 2016$266,000
-48.4%
29,800
-14.9%
0.00%
-50.0%
Q4 2015$516,000
-8.3%
35,000
+2.0%
0.01%
-14.3%
Q3 2015$563,000
-24.3%
34,300
+5.2%
0.01%
-22.2%
Q2 2015$744,000
+89.8%
32,600
+26.4%
0.01%
+80.0%
Q1 2015$392,000
+17.0%
25,800
-8.2%
0.01%
+25.0%
Q4 2014$335,000
-5.1%
28,100
-9.6%
0.00%
-20.0%
Q3 2014$353,000
-3.0%
31,100
+3.3%
0.01%0.0%
Q2 2014$364,000
-1.1%
30,100
-4.7%
0.01%
-16.7%
Q1 2014$368,000
-31.3%
31,600
+6.0%
0.01%
-33.3%
Q4 2013$536,000
+28.5%
29,800
+2.8%
0.01%
+28.6%
Q3 2013$417,00029,0000.01%
Other shareholders
MOMENTA PHARMACEUTICALS INC shareholders Q2 2018
NameSharesValueWeighting ↓
Opaleye Management Inc. 450,000$7,605,0003.18%
ARMISTICE CAPITAL, LLC 820,000$13,858,0001.77%
Marcus Capital, LLC 104,000$1,758,0001.50%
SECTOR GAMMA AS 605,545$10,234,0001.49%
Palo Alto Investors LP 1,787,576$30,210,0001.41%
SECTORAL ASSET MANAGEMENT INC 299,400$5,060,0000.55%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 433,060$7,318,0000.53%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT 1,232,929$20,837,0000.51%
Orbimed Advisors 2,109,068$35,643,0000.37%
TFS CAPITAL LLC 52,290$884,0000.35%
View complete list of MOMENTA PHARMACEUTICALS INC shareholders